Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:AKRX

Akorn (AKRX) Stock Price, News & Analysis

Akorn logo

About Akorn Stock (NASDAQ:AKRX)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$0.09
$0.32
52-Week Range
N/A
Volume
1.19 million shs
Average Volume
9.60 million shs
Market Capitalization
$3.60 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive AKRX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Akorn and its competitors with MarketBeat's FREE daily newsletter.

AKRX Stock News Headlines

Akorn Reaches New 52-Week High (AKRX)
"I'm risking my reputation on this"
Behind closed doors, away from the mainstream media's eyes, the smartest minds in crypto are all seeing the same signals. They're positioning themselves for something unprecedented. And after 17 million podcast downloads and over 600 insider interviews, I finally connected all the dots… What I discovered was so explosive, so potentially life-changing, that I had to put it all in a book.
See More Headlines

AKRX Stock Analysis - Frequently Asked Questions

Akorn, Inc. (NASDAQ:AKRX) released its quarterly earnings data on Monday, May, 11th. The company reported $0.36 earnings per share for the quarter, beating the consensus estimate of ($0.09) by $0.45. The firm had revenue of $204.69 million for the quarter, compared to analyst estimates of $168.90 million. Akorn had a negative net margin of 55.64% and a positive trailing twelve-month return on equity of 8.53%.

Based on aggregate information from My MarketBeat watchlists, some other companies that Akorn investors own include Bristol Myers Squibb (BMY), Integrated Device Technology (IDTI), Skechers U.S.A. (SKX), Rite Aid (RAD), Lannett (LCI), Bank of America (BAC) and Quantenna Communications (QTNA).

Company Calendar

Last Earnings
5/11/2020
Today
7/13/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
Pharmaceuticals
Current Symbol
NASDAQ:AKRX
CIK
3116
Fax
N/A
Employees
2,227
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($0.34)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$226.77 million
Net Margins
-55.64%
Pretax Margin
N/A
Return on Equity
8.53%
Return on Assets
1.31%

Debt

Debt-to-Equity Ratio
0.09
Current Ratio
0.50
Quick Ratio
0.32

Sales & Book Value

Annual Sales
$682.43 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
0.19
Book Value
$1.86 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
133,152,000
Free Float
N/A
Market Cap
$3.60 million
Optionable
Optionable
Beta
0.95
These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

This page (NASDAQ:AKRX) was last updated on 7/13/2025 by MarketBeat.com Staff
From Our Partners